Nose-to-brain delivery of borneol modified tanshinone IIA nanoparticles in prevention of cerebral ischemia/reperfusion injury

Abstract Targeted treatment of cerebral ischemia/reperfusion injury (CIRI) remains a problem due to the difficulty in drug delivery across the blood–brain barrier (BBB). In this study, we developed Bo-TSA-NP, a novel tanshinone IIA (TSA) loaded nanoparticles modified by borneol, which has long been proved with the ability to enhance other drugs’ transport across the BBB. The Bo-TSA-NP, with a particle size of about 160 nm, drug loading of 3.6%, showed sustained release and P-glycoprotein (P-gp) inhibition property. It demonstrated a significantly higher uptake by 16HBE cells in vitro through the clathrin/caveolae-mediated endocytosis and micropinocytosis. Following intranasal (IN) administration, Bo-TSA-NP significantly improved the preventive effect on a rat model of CIRI with improved neurological scores, decreased cerebral infarction areas and a reduced content of malondialdehyde (MDA) and increased activity of superoxide dismutase (SOD) in rat brain. In conclusion, these results indicate that Bo-TSA-NP is a promising nose-to-brain delivery system that can enhance the prevention effect of TSA on CIRI.

[1]  Xuefeng Xiong,et al.  Borneol-modified tanshinone IIA liposome improves cerebral ischemia reperfusion injury by suppressing NF-κB and ICAM-1 expression , 2021, Drug development and industrial pharmacy.

[2]  Chuan Hu,et al.  The construction of in vitro nasal cavity-mimic M-cell model, design of M cell-targeting nanoparticles and evaluation of mucosal vaccination by nasal administration , 2020, Acta pharmaceutica Sinica. B.

[3]  N. Alhakamy,et al.  Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease. , 2020, International journal of pharmaceutics.

[4]  Xin Ma,et al.  Metabolomics Study on the Effects of Salvianolic Acid B and Borneol for Treating Cerebral Ischemia in Rats by Ultra-Performance Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry. , 2019, Rejuvenation research.

[5]  Kaili Hu,et al.  Improved brain delivery of pueraria flavones via intranasal administration of borneol-modified solid lipid nanoparticles. , 2019, Nanomedicine.

[6]  K. Schindowski,et al.  Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa , 2018, Pharmaceutics.

[7]  Jian Wang,et al.  The protective roles of L-borneolum, D-borneolum and synthetic borneol in cerebral ischaemia via modulation of the neurovascular unit. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[8]  Giou-Teng Yiang,et al.  Current Mechanistic Concepts in Ischemia and Reperfusion Injury , 2018, Cellular Physiology and Biochemistry.

[9]  Ruhui Lin,et al.  Mechanism of salvianolic acid B neuroprotection against ischemia/reperfusion induced cerebral injury , 2018, Brain Research.

[10]  Mengrui Liu,et al.  Progress in brain targeting drug delivery system by nasal route , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[11]  L. Dai,et al.  Drug resistance reversal in ovarian cancer cells of paclitaxel and borneol combination therapy mediated by PEG-PAMAM nanoparticles , 2017, Oncotarget.

[12]  Huile Gao,et al.  Progress and perspectives on targeting nanoparticles for brain drug delivery , 2016, Acta pharmaceutica Sinica. B.

[13]  M. Moro,et al.  The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia. , 2016, Current pharmaceutical design.

[14]  Chen Weian,et al.  Protective effects of mangiferin on cerebral ischemia-reperfusion injury and its mechanisms. , 2016, European journal of pharmacology.

[15]  Meiwan Chen,et al.  Recent insights into the biological activities and drug delivery systems of tanshinones , 2016, International journal of nanomedicine.

[16]  Yuefei Wang,et al.  Borneol Depresses P-Glycoprotein Function by a NF-κB Signaling Mediated Mechanism in a Blood Brain Barrier in Vitro Model , 2015, International journal of molecular sciences.

[17]  N. Ferrer-Miralles,et al.  BBB-targeting, protein-based nanomedicines for drug and nucleic acid delivery to the CNS. , 2015, Biotechnology advances.

[18]  Junqing Yang,et al.  Time course change of COX2-PGI2/TXA2 following global cerebral ischemia reperfusion injury in rat hippocampus , 2014, Behavioral and Brain Functions.

[19]  N. Zhang,et al.  Diosmin protects against cerebral ischemia/reperfusion injury through activating JAK2/STAT3 signal pathway in mice , 2014, Neuroscience.

[20]  C. Rosen,et al.  The science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future success. , 2013, Journal of neurosurgery.

[21]  Xiang Yun,et al.  Nanoparticles for Targeted Delivery of Antioxidant Enzymes to the Brain after Cerebral Ischemia and Reperfusion Injury , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  P. Gao,et al.  Tissue distribution of borneol-modified ganciclovir-loaded solid lipid nanoparticles in mice after intravenous administration. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[23]  M. Nireekshan Kumar,et al.  Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[24]  Chi-Rei Wu,et al.  Green Tea Extract Ameliorates Learning and Memory Deficits in Ischemic Rats via Its Active Component Polyphenol Epigallocatechin-3-gallate by Modulation of Oxidative Stress and Neuroinflammation , 2012, Evidence-based complementary and alternative medicine : eCAM.

[25]  R. Thorne,et al.  Intranasal delivery of biologics to the central nervous system. , 2012, Advanced drug delivery reviews.

[26]  Lianfeng Zhang,et al.  Protection by borneol on cortical neurons against oxygen-glucose deprivation/reperfusion: involvement of anti-oxidation and anti-inflammation through nuclear transcription factor κappaB signaling pathway , 2011, Neuroscience.

[27]  A. Wu,et al.  The effects of Tanshinone IIA on blood-brain barrier and brain edema after transient middle cerebral artery occlusion in rats. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[28]  G. M. Pollack,et al.  Examination of the ability of the nasal administration route to confer a brain exposure advantage for three chemical inhibitors of P-glycoprotein. , 2010, Journal of pharmaceutical sciences.

[29]  Chi-Hsien Liu,et al.  Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery , 2010, Drug development and industrial pharmacy.

[30]  Wei Du,et al.  The neuroprotective effects of Tanshinone IIA are associated with induced nuclear translocation of TORC1 and upregulated expression of TORC1, pCREB and BDNF in the acute stage of ischemic stroke , 2010, Brain Research Bulletin.

[31]  Yang Lu,et al.  The in situ and in vivo study on enhancing effect of borneol in nasal absorption of Geniposide in rats , 2010, Archives of pharmacal research.

[32]  S. Pasha,et al.  Various drug delivery approaches to the central nervous system , 2010, Expert opinion on drug delivery.

[33]  B. Nambisan,et al.  Dietary mucilage promotes regression of atheromatous lesions in hypercholesterolemic rabbits , 2009, Phytotherapy research : PTR.

[34]  Sriparna Basu,et al.  Free Radical Injury and Blood-Brain Barrier Permeability in Hypoxic-Ischemic Encephalopathy , 2008, Pediatrics.

[35]  T. Hibi,et al.  Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. , 2008, Pharmacology & therapeutics.

[36]  Yasuo Katayama,et al.  Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals , 2007, Nature Medicine.

[37]  Xingshun Xu,et al.  Humanin Is a Novel Neuroprotective Agent Against Stroke , 2006, Stroke.

[38]  P. Mecocci,et al.  Potential markers of oxidative stress in stroke. , 2005, Free radical biology & medicine.

[39]  Xin-guo Jiang,et al.  Preparation, characterization and application of pyrene-loaded methoxy poly(ethylene glycol)–poly(lactic acid) copolymer nanoparticles , 2004 .

[40]  L. Illum.  Nasal drug delivery: new developments and strategies. , 2002, Drug discovery today.

[41]  C. Yang,et al.  Protection of cultured rat cortical neurons from excitotoxicity by asarone, a major essential oil component in the rhizomes of Acorus gramineus. , 2002, Life sciences.

[42]  Liu Bilin,et al.  Optimization of preparation of curcumin-catanionic nanoparticles lipid carriers by central composite design-response surface methodology , 2016 .

[43]  Paul Southern,et al.  Real-time tracking of delayed-onset cellular apoptosis induced by intracellular magnetic hyperthermia. , 2016, Nanomedicine.

[44]  M. Ruan,et al.  The mechanism of the opening of the blood-brain barrier by borneol: a pharmacodynamics and pharmacokinetics combination study. , 2013, Journal of ethnopharmacology.

[45]  P. Weinstein,et al.  Reversible middle cerebral artery occlusion without craniectomy in rats. , 1989, Stroke.